Bradley Wiggins hinted at extending his career after finishing second in the London Six Day with Mark Cavendish on Sunday.
“I’ve enjoyed it that much, I just don’t know at the moment,” he said following a comment that “money talks.”
“I’d love to still be part of it in the future. I still love riding my bike, I love racing. Who wouldn’t want to come back, with a week like this and the crowds like this? It’s been incredible.”
Wiggins and teammate Mark Cavendish finished second in the series and are set to race the Ghent Six Day event which is billed as Wiggins’ final pro race.
He had declined to speak with the media during the entire event, likely due to the controversy embroiling him and Team Sky at the moment.
Data stolen by hackers from files held by the World Anti-Doping Agency showed Wiggins received three therapeutic use exemptions (TUEs) for anti-inflammatory drug triamcinolone – a substance which has a history of abuse in cycling and is otherwise banned – on the eve of the 2011 and 2012 Tours de France and 2013 Giro d’Italia.
Wiggins, who in 2012 became the first British winner of the Tour, and Team Sky principal Sir Dave Brailsford strenuously deny wrongdoing, insisting the injections were medically necessary to deal with a pollen allergy that aggravates Wiggins’ long-standing asthma condition.